DNAnexus Expands its Global Network for Genomic Medicine to China

Global Network for Genomic MedicineIt’s official – DNAnexus is expanding its cloud platform to China. A $15 million strategic investment and alliance with WuXi PharmaTech will bring cloud-based genomics to China and Chinese genomics to the world. We’ve been steadily building the global network for genomic medicine, and now we can serve the Chinese life science market.

With our leading genome informatics and data management cloud technology, DNAnexus is connecting WuXi NextCODE’s sequence data analysis suite and WuXi PharmaTech’s global, open access drug discovery and development services on a single platform. You can read more about our announcement in:


Why China?

China currently holds more than 20% of the world’s sequencing capacity and with a population approaching 1.4 billion and its ability to test and enhance new ideas, China represents the largest market in the world for next-generation sequencing. DNAnexus customers are global in scope and needed a China cloud solution to support their efforts. Pharmaceutical customers using contract research services in China will now have a seamless end-to-end HIPAA compliant platform to expand clinical research with collaborations and datasets and speed the development and delivery of DNA-based diagnostics.

This strategic alliance provides not just a China solution, but also a global solution. It unites the leading technologies to enable any company or institution to store and interpret their sequence data and collaborate with colleagues around the world through a single platform. For the first time, users will be able to use their genomic data seamlessly in tandem with the open access capability and technology (e.g. diagnostic test validation or FDA submission services) that WuXi offers to the global pharmaceutical and medical device industry.

Empowering Virtual Diagnostics

China is just one piece of the puzzle, albeit a big one. We envision this alliance fueling innovation and transforming large-scale sequence data business models, and laying the groundwork for virtual diagnostics enterprises to develop and deploy clinical and companion diagnostics in the cloud. By connecting the DNAnexus compliant cloud-based bioinformatics platform with WuXi leading genomics and R&D services, companies are able to focus on their intellectual property, and the development of algorithms and pipelines. WuXi and DNAnexus will facilitate groundbreaking virtual test development and deployment on a global basis, without the need for capital investment in test development and compute infrastructure.

Yes, we are scaling up our engineering team!

We are looking for smart motivated people. Leave your lab coat at home. Our core is building great software, the technology that powers our genomics data platform. Learn more about career opportunities at DNAnexus.

We are on the forefront of precision medicine, bringing together proven informatics for population-scale genome sequence data, the latest secure cloud technology, and the global reach of the Internet.

The Word “Genetics” is 110 Years Old

William Bateson

William Bateson, an advocate of Gregor Mendel’s ideas, first proposed the use of the word “genetics” in a letter to a colleague dated April 18, 1905. The new word subsequently entered the scientific lexicon when Bateson used it to describe the study of inheritance in his inaugural address to the Third International Conference on Plant Hybridization in London, England in 1906.

But why did the ideas of Gregor Mendel, now so well known as Mendel’s Laws of Inheritance, need an advocate? The answer has to do with management, delivery, and collaborative access to scientific information.

Mendel’s paper “Experiments on Plant Hybridization” was read by the author at a scientific conference in 1865, and was published in 1866. But the ideas put forth, thus spoken and written, were not “dusted off” and put to use until some 35 years later, when biologists of the early 20th century finally discovered how readily they could explain and predict their own experimental observations. Eventually, William Bateson realized that Mendel had already carried out experiments that Bateson himself had proposed in the intervening years.

Who knows where we would be today if Mendel’s ideas had not been overlooked for the duration of an entire human generation?

In terms of information management, accessibility, and analysis, we’ve come a long way since the times of Mendel and Bateson, and at DNAnexus, we’re proud of our place on the leading edge of these ongoing, historic changes affecting humanity. And while we can’t guarantee that future, great scientific concepts will be recognized as such with immediacy, we do our very best to provide users of the DNAnexus platform immediate and secure access to genomic information, not just for storage, retrieval, and analysis, but for facilitation of the astounding advantages of scientific collaboration.

With advances in sequencing technology, the size and scope of DNA sequencing projects is rapidly moving toward an era when hundreds of thousands of whole genomes and will be sequenced each year. With an annual throughput capacity of 18,000 whole genomes, the Garvan Institute’s Kinghorn Centre of Clinical Genomics has laid claim to a substantial role in the future of scientific inquiry and personalized medicine. DNAnexus has enabled the Garvan Institute to manage the data security, delivery, analysis and collaboration requirements of productively sequencing 150 whole genomes every three days.  Learn more.

DNAnexus at Bio-IT World: Population-Scale NGS Studies Enter the Cloud

BioIT World 2015We are excited to be heading to Boston next week to participate in the annual Bio-IT World Conference & Expo at the Seaport World Trade Center. Reflecting the needs and interests of attendees, the conference organizers have prepared a program featuring cloud computing as a central and pervasive topic. Cloud computing appears not only as its own dedicated track, but, in addition, as a focal point in many of the other conference tracks.

With twelve concurrent tracks in all, and so many great opportunities to learn about high-performance computing, data analysis, data security, IT management, and, of course, the cloud, it can be challenging to plan one’s own way around the conference. Here, for our customers and others interested in the most productive ways to manage and analyze genomic data, are our top recommendations:

To learn more about DNAnexus and see a demo of the DNAnexus platform, visit booth #217 in the exhibit hall at the Bio-IT World Conference & Expo.